Balchem (BCPC) Financials

$169.02 +3.06 (+1.84%)

Closing price 04:00 PM Eastern

Extended Trading

$168.94 -0.09 (-0.05%)

As of 04:20 PM Eastern

Annual Income Statements for Balchem

This table shows Balchem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	128	109	105	96	85	80	79	90	56	60
Consolidated Net Income / (Loss)	128	109	105	96	85	80	79	90	56	60
Net Income / (Loss) Continuing Operations	128	109	105	96	85	80	79	90	56	60
Total Pre-Tax Income	166	137	134	125	106	96	99	88	83	87
Total Operating Income	183	159	145	128	111	103	107	97	91	94
Total Gross Profit	336	302	280	243	224	211	204	189	181	168
Total Revenue	954	922	942	799	704	644	644	595	553	552
Operating Revenue	954	922	942	799	704	644	644	595	553	552
Total Cost of Revenue	617	620	662	556	480	432	439	406	372	384
Operating Cost of Revenue	617	620	662	556	480	432	439	406	372	384
Total Operating Expenses	153	143	135	116	113	109	97	92	90	74
Selling, General & Admin Expense	137	128	123	102	102	97	86	83	83	68
Research & Development Expense	17	15	12	14	10	11	12	9.31	7.33	5.99
Total Other Income / (Expense), net	-16	-22	-11	-2.27	-4.73	-6.08	-8.07	-8.42	-7.90	-6.89
Interest & Investment Income	-17	-23	-10	-	-	-	-	-	-	0.01
Other Income / (Expense), net	0.07	0.68	-1.17	0.19	-0.29	-0.12	-0.46	-0.88	-0.65	-0.31
Income Tax Expense	38	29	28	29	22	17	20	-1.58	27	27
Basic Earnings per Share	$3.97	$3.38	$3.29	$2.98	$2.63	$2.48	$2.45	$2.83	$1.78	$1.92
Weighted Average Basic Shares Outstanding	32.53M	32.27M	32.17M	32.19M	32.39M	32.25M	32.09M	31.84M	31.52M	31.16M
Diluted Earnings per Share	$3.93	$3.35	$3.25	$2.94	$2.60	$2.45	$2.42	$2.79	$1.75	$1.89
Weighted Average Diluted Shares Outstanding	32.53M	32.27M	32.17M	32.19M	32.39M	32.25M	32.09M	31.84M	31.52M	31.16M
Weighted Average Basic & Diluted Shares Outstanding	32.53M	32.27M	32.17M	32.19M	32.39M	32.25M	32.09M	31.84M	31.52M	31.16M
Cash Dividends to Common per Share	$0.87	$0.79	$0.71	-	-	-	-	-	-	-

This table shows Balchem's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	37	34	34	32	29	27	29	30	23	21	25
Consolidated Net Income / (Loss)	37	34	34	32	29	27	29	30	23	21	25
Net Income / (Loss) Continuing Operations	37	34	34	32	29	27	29	30	23	21	25
Total Pre-Tax Income	48	44	44	41	37	33	36	38	29	26	31
Total Operating Income	51	47	48	46	42	38	44	43	34	33	34
Total Gross Profit	88	86	85	83	82	75	77	77	73	69	68
Total Revenue	251	240	240	234	240	229	230	231	233	233	244
Operating Revenue	251	240	240	234	240	229	230	231	233	233	244
Total Cost of Revenue	162	154	155	151	158	154	153	154	159	164	176
Operating Cost of Revenue	162	154	155	151	158	154	153	154	159	164	176
Total Operating Expenses	37	39	37	37	40	37	33	35	39	35	35
Selling, General & Admin Expense	32	34	33	33	36	33	29	31	35	32	32
Research & Development Expense	4.66	4.51	4.33	3.85	4.10	3.94	3.87	3.80	3.45	3.04	3.00
Total Other Income / (Expense), net	-3.08	-2.96	-4.10	-4.57	-4.83	-5.07	-7.14	-4.44	-5.29	-7.69	-2.54
Interest & Investment Income	-2.92	-	-4.07	-4.24	-	-	-6.59	-5.16	-	-	-
Other Income / (Expense), net	-0.15	-0.14	-0.03	-0.33	0.57	0.22	-0.55	0.73	0.28	-	1.10
Income Tax Expense	11	11	10	9.16	7.86	6.62	7.40	8.29	6.41	4.37	5.84
Basic Earnings per Share	$1.14	$1.03	$1.05	$0.99	$0.90	$0.82	$0.91	$0.94	$0.71	$0.67	$0.79
Weighted Average Basic Shares Outstanding	32.62M	32.53M	32.51M	32.44M	32.42M	32.27M	32.24M	32.24M	32.23M	32.17M	32.14M
Diluted Earnings per Share	$1.13	$1.03	$1.03	$0.98	$0.89	$0.82	$0.90	$0.93	$0.70	$0.66	$0.78
Weighted Average Diluted Shares Outstanding	32.62M	32.53M	32.51M	32.44M	32.42M	32.27M	32.24M	32.24M	32.23M	32.17M	32.14M
Weighted Average Basic & Diluted Shares Outstanding	32.62M	32.53M	32.51M	32.44M	32.42M	32.27M	32.24M	32.24M	32.23M	32.17M	32.14M

This table details how cash moves in and out of Balchem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-15	-2.11	-37	19	19	11	14	1.77	-46	35
Net Cash From Operating Activities	182	184	139	161	150	124	119	111	108	104
Net Cash From Continuing Operating Activities	182	184	139	161	150	124	119	111	108	104
Net Income / (Loss) Continuing Operations	128	109	105	96	85	80	79	90	56	60
Consolidated Net Income / (Loss)	128	109	105	96	85	80	79	90	56	60
Depreciation Expense	48	55	52	49	51	46	45	44	46	40
Non-Cash Adjustments To Reconcile Net Income	19	22	15	11	11	7.45	4.87	6.93	7.59	4.25
Changes in Operating Assets and Liabilities, net	-13	-2.10	-34	4.99	3.91	-8.52	-9.41	-31	-2.15	-0.11
Net Cash From Investing Activities	-60	-35	-416	-35	-35	-156	-32	-43	-134	-42
Net Cash From Continuing Investing Activities	-60	-35	-416	-35	-35	-156	-32	-43	-134	-42
Purchase of Property, Plant & Equipment	-36	-38	-50	-37	-34	-28	-20	-28	-23	-41
Acquisitions	-24	-1.25	-366	0.00	0.00	-141	-17	-17	-112	-1.01
Purchase of Investments	-0.27	-0.29	-0.50	-0.09	-0.85	-1.00	0.00	0.00	-	-
Sale of Property, Plant & Equipment	0.36	1.88	0.21	0.32	0.09	12	0.97	0.02	0.00	0.03
Sale and/or Maturity of Investments	0.00	2.74	0.00	0.00	-	-	-	-	-	0.00
Net Cash From Financing Activities	-134	-153	247	-102	-101	43	-71	-69	-19	-26
Net Cash From Continuing Financing Activities	-134	-153	247	-102	-101	43	-71	-69	-19	-26
Repayment of Debt	-146	-149	-135	-60	-95	-94	-276	-89	-89	-35
Repurchase of Common Equity	-5.68	-4.47	-35	-35	-13	-21	-1.39	-1.91	-1.59	-1.21
Payment of Dividends	-26	-23	-21	-19	-17	-15	-13	-12	-11	-9.25
Issuance of Debt	26	18	435	5.00	10	169	211	25	73	-
Other Financing Activities, net	17	5.02	3.04	6.78	14	4.84	8.27	9.73	9.74	20
Effect of Exchange Rate Changes	-3.38	2.26	-5.88	-4.37	4.16	-0.22	-1.41	2.48	-0.72	-1.20

This table details how cash moves in and out of Balchem's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	0.39	-24	9.96	3.39	-4.10	-13	10	6.66	-6.36	10	-20
Net Cash From Operating Activities	36	52	51	45	33	67	47	35	35	42	42
Net Cash From Continuing Operating Activities	36	52	51	45	33	67	47	35	35	42	42
Net Income / (Loss) Continuing Operations	37	34	34	32	29	27	29	30	23	21	25
Consolidated Net Income / (Loss)	37	34	34	32	29	27	29	30	23	21	25
Depreciation Expense	11	11	11	13	14	14	14	13	14	14	14
Non-Cash Adjustments To Reconcile Net Income	3.68	4.76	5.04	4.63	4.10	4.04	5.50	9.36	3.48	5.67	1.55
Changes in Operating Assets and Liabilities, net	-15	3.07	1.53	-4.22	-13	23	-1.86	-18	-5.00	0.69	0.72
Net Cash From Investing Activities	-5.91	-37	-9.18	-6.86	-6.74	-12	-9.28	-3.61	-10	-14	-85
Net Cash From Continuing Investing Activities	-5.91	-37	-9.18	-6.86	-6.74	-12	-9.28	-3.61	-10	-14	-85
Purchase of Property, Plant & Equipment	-5.56	-13	-9.15	-6.88	-6.91	-12	-8.30	-8.22	-9.66	-14	-15
Acquisitions	-0.32	-24	-	-	0.00	-	-0.91	-	-0.34	-	-70
Purchase of Investments	-0.03	-0.16	-0.03	-0.04	-0.04	-0.15	-0.07	-0.02	-0.06	-0.35	-
Sale of Property, Plant & Equipment	0.00	-	-	-	-	-	-	-	-	-	-
Net Cash From Financing Activities	-32	-35	-34	-34	-30	-70	-25	-25	-33	-21	28
Net Cash From Continuing Financing Activities	-32	-35	-34	-34	-30	-70	-25	-25	-33	-21	28
Repayment of Debt	-29	-37	-40	-35	-34	-71	-30	-26	-22	-22	-42
Repurchase of Common Equity	-5.33	-0.31	-0.16	-0.01	-5.20	-0.44	-0.10	-0.08	-3.85	-0.18	-0.05
Payment of Dividends	-28	-0.00	-0.00	-0.01	-26	-	-0.00	-0.00	-23	-0.01	-0.00
Issuance of Debt	29	-	-	-	26	-	5.00	-	13	-	70
Other Financing Activities, net	1.62	2.10	5.34	0.84	8.73	1.30	0.01	1.32	2.40	0.99	0.80
Effect of Exchange Rate Changes	1.81	-4.32	2.23	-0.56	-0.72	2.10	-2.06	0.04	2.18	4.31	-4.59

This table presents Balchem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	1,575	1,597	1,625	1,199	1,166	1,156	981	964	949	880
Total Current Assets	314	314	336	322	267	255	226	199	188	198
Cash & Equivalents	50	64	67	103	85	66	54	40	39	85
Accounts Receivable	120	125	132	117	98	93	100	91	83	60
Inventories, net	131	110	120	91	71	84	67	61	57	46
Prepaid Expenses	8.05	7.80	4.90	6.12	6.60	4.39	3.83	4.77	4.11	3.21
Other Current Assets	5.74	7.19	13	4.41	3.44	2.45	1.48	2.22	4.48	2.91
Plant, Property, & Equipment, net	282	276	271	238	228	217	191	190	166	159
Total Noncurrent Assets	979	1,007	1,017	640	671	684	564	575	594	523
Noncurrent Note & Lease Receivables	1.73	2.10	2.34	2.36	2.57	-	-	-	-	-
Goodwill	780	779	770	524	529	524	448	441	440	384
Intangible Assets	165	191	213	95	122	144	109	128	147	135
Other Noncurrent Operating Assets	33	35	32	19	17	16	6.72	5.07	7.14	4.06
Total Liabilities & Shareholders' Equity	1,575	1,597	1,625	1,199	1,166	1,156	981	964	949	880
Total Liabilities	425	543	686	322	338	412	290	347	428	416
Total Current Liabilities	158	148	140	144	94	92	82	108	101	81
Accounts Payable	55	56	57	56	24	37	33	28	33	15
Accrued Expenses	44	41	37	43	30	25	22	23	15	13
Dividends Payable	29	26	23	21	19	17	15	13	12	11
Current Deferred & Payable Income Tax Liabilities	4.47	4.97	2.28	1.33	0.00	-	0.44	-	-	2.73
Current Employee Benefit Liabilities	23	17	17	20	20	11	11	8.53	6.65	5.13
Other Current Liabilities	3.33	4.22	4.02	2.36	2.34	2.48	-	-	-	-
Total Noncurrent Liabilities	268	395	546	179	243	320	208	238	327	335
Long-Term Debt	209	326	467	109	174	256	163	190	252	268
Capital Lease Obligations	1.75	1.94	2.21	2.30	2.47	-	0.00	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	44	52	63	46	51	56	44	49	74	67
Other Noncurrent Operating Liabilities	13	15	14	21	15	6.93	0.00	-	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,150	1,054	938	877	828	744	692	617	521	464
Total Preferred & Common Equity	1,150	1,054	938	877	828	744	692	617	521	464
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,150	1,054	938	877	828	744	692	617	521	464
Common Stock	176	148	131	150	167	176	167	154	140	125
Retained Earnings	997	897	814	732	657	591	528	465	388	344
Accumulated Other Comprehensive Income / (Loss)	-24	8.69	-7.15	-4.99	4.17	-5.56	-3.60	-1.64	-6.85	-5.11

This table presents Balchem's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,618	1,597	1,575	1,589	1,603	1,619	1,629	1,633
Total Current Assets	340	326	320	325	341	337	336	368
Cash & Equivalents	50	74	64	60	77	67	60	56
Accounts Receivable	130	121	123	140	129	125	131	141
Inventories, net	145	119	117	110	116	125	125	139
Prepaid Expenses	8.13	7.83	9.96	7.12	7.24	8.83	7.43	6.94
Other Current Assets	6.83	5.42	5.96	7.13	6.59	7.24	12	20
Plant, Property, & Equipment, net	284	277	273	274	269	271	276	260
Total Noncurrent Assets	994	994	982	990	993	1,011	1,017	1,005
Noncurrent Note & Lease Receivables	1.68	1.78	1.98	2.04	2.16	2.22	2.28	2.20
Goodwill	793	781	770	772	767	774	774	749
Intangible Assets	166	178	176	182	192	203	209	227
Other Noncurrent Operating Assets	33	33	34	34	33	32	31	26
Total Liabilities & Shareholders' Equity	1,618	1,597	1,575	1,589	1,603	1,619	1,629	1,633
Total Liabilities	409	420	463	510	578	612	655	737
Total Current Liabilities	140	109	113	124	108	114	117	142
Accounts Payable	66	46	55	60	50	56	53	73
Accrued Expenses	44	40	37	38	43	41	43	50
Dividends Payable	0.13	0.05	0.05	0.07	0.18	0.19	0.19	0.13
Current Deferred & Payable Income Tax Liabilities	14	1.96	3.44	12	0.00	0.00	7.88	0.00
Current Employee Benefit Liabilities	12	18	15	11	12	13	9.22	15
Other Current Liabilities	3.92	3.40	3.84	4.05	3.86	4.09	3.06	3.90
Total Noncurrent Liabilities	269	310	349	385	470	498	539	595
Long-Term Debt	210	245	284	319	396	421	461	477
Capital Lease Obligations	1.70	1.80	1.85	1.90	2.00	2.10	2.16	2.17
Noncurrent Deferred & Payable Income Tax Liabilities	45	50	50	51	59	62	63	77
Other Noncurrent Operating Liabilities	12	13	14	14	13	13	13	39
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,209	1,177	1,112	1,079	1,025	1,007	973	896
Total Preferred & Common Equity	1,209	1,177	1,112	1,079	1,025	1,007	973	896
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,209	1,177	1,112	1,079	1,025	1,007	973	896
Common Stock	176	170	161	156	143	139	134	127
Retained Earnings	1,035	992	959	926	896	867	837	816
Accumulated Other Comprehensive Income / (Loss)	-2.26	15	-7.13	-3.87	-14	0.19	1.86	-47

This table displays calculated financial ratios and metrics derived from Balchem's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.39%	-2.11%	17.94%	13.56%	9.31%	0.00%	8.22%	7.52%	0.13%	2.05%
EBITDA Growth	7.52%	9.67%	10.93%	8.90%	9.33%	-1.99%	7.77%	2.94%	2.08%	18.60%
EBIT Growth	14.45%	11.01%	12.79%	15.18%	8.22%	-3.94%	11.06%	6.46%	-3.69%	14.02%
NOPAT Growth	12.15%	10.06%	16.90%	10.70%	4.37%	-0.34%	-13.85%	60.89%	-4.88%	14.44%
Net Income Growth	18.36%	3.01%	9.64%	13.57%	6.22%	1.40%	-12.77%	60.92%	-6.28%	13.05%
EPS Growth	17.31%	3.08%	10.54%	13.08%	6.12%	1.24%	-13.26%	59.43%	-7.41%	11.83%
Operating Cash Flow Growth	-0.96%	32.64%	-13.69%	6.66%	20.92%	4.86%	7.30%	2.79%	3.65%	21.65%
Free Cash Flow Firm Growth	-1.68%	142.66%	-362.06%	30.86%	298.49%	-160.41%	27.46%	332.51%	-145.99%	112.33%
Invested Capital Growth	-0.25%	-1.55%	50.68%	-3.58%	-1.27%	16.58%	0.15%	4.21%	12.94%	0.43%
Revenue Q/Q Growth	1.20%	-0.41%	2.10%	4.23%	2.06%	0.47%	0.67%	3.21%	1.47%	-5.14%
EBITDA Q/Q Growth	2.48%	2.81%	-0.03%	2.41%	3.75%	-1.45%	0.38%	0.88%	3.08%	-3.62%
EBIT Q/Q Growth	5.02%	3.70%	-1.16%	3.94%	5.02%	-3.18%	0.55%	1.95%	2.74%	-4.91%
NOPAT Q/Q Growth	3.75%	2.58%	1.72%	2.74%	1.52%	-0.42%	-21.51%	40.45%	0.46%	-5.19%
Net Income Q/Q Growth	5.71%	5.07%	-3.25%	2.99%	2.15%	0.06%	-21.59%	40.69%	0.48%	-5.33%
EPS Q/Q Growth	5.65%	5.02%	-2.69%	2.44%	2.36%	0.00%	-21.94%	40.20%	0.00%	-5.03%
Operating Cash Flow Q/Q Growth	-7.66%	16.30%	-2.01%	-2.11%	11.06%	-5.00%	7.57%	3.14%	2.69%	-9.68%
Free Cash Flow Firm Q/Q Growth	9.34%	53.96%	-20.73%	11.53%	115.14%	-635.29%	15.64%	-2.38%	29.25%	-21.32%
Invested Capital Q/Q Growth	-0.76%	-0.23%	3.43%	-1.72%	-0.51%	5.27%	-1.46%	2.84%	-0.95%	0.57%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.25%	32.75%	29.76%	30.43%	31.82%	32.84%	31.73%	31.78%	32.69%	30.43%
EBITDA Margin	24.22%	23.29%	20.78%	22.10%	23.04%	23.04%	23.51%	23.60%	24.65%	24.18%
Operating Margin	19.18%	17.26%	15.41%	15.96%	15.80%	15.93%	16.64%	16.29%	16.42%	17.01%
EBIT Margin	19.19%	17.33%	15.28%	15.98%	15.75%	15.91%	16.57%	16.14%	16.30%	16.95%
Profit (Net Income) Margin	13.47%	11.77%	11.18%	12.03%	12.03%	12.38%	12.21%	15.14%	10.12%	10.81%
Tax Burden Percent	77.18%	79.08%	78.78%	76.74%	79.52%	82.58%	79.34%	101.79%	67.49%	68.60%
Interest Burden Percent	90.97%	85.86%	92.87%	98.08%	96.00%	94.18%	92.86%	92.16%	91.95%	92.97%
Effective Tax Rate	22.82%	20.92%	21.22%	23.26%	20.48%	17.42%	20.66%	-1.79%	32.51%	31.40%
Return on Invested Capital (ROIC)	10.52%	9.30%	10.08%	10.61%	9.35%	9.58%	10.42%	12.36%	8.32%	9.33%
ROIC Less NNEP Spread (ROIC-NNEP)	5.22%	4.45%	6.11%	8.11%	6.99%	6.56%	6.45%	8.62%	6.14%	7.53%
Return on Net Nonoperating Assets (RNNOA)	1.14%	1.60%	1.53%	0.66%	1.42%	1.52%	1.59%	3.48%	3.05%	4.63%
Return on Equity (ROE)	11.66%	10.90%	11.61%	11.27%	10.77%	11.10%	12.01%	15.83%	11.37%	13.96%
Cash Return on Invested Capital (CROIC)	10.77%	10.86%	-30.36%	14.25%	10.63%	-5.73%	10.28%	8.23%	-3.84%	8.90%
Operating Return on Assets (OROA)	11.54%	9.92%	10.20%	10.80%	9.55%	9.59%	10.97%	10.04%	9.87%	10.76%
Return on Assets (ROA)	8.10%	6.74%	7.46%	8.13%	7.29%	7.46%	8.08%	9.42%	6.12%	6.86%
Return on Common Equity (ROCE)	11.66%	10.90%	11.61%	11.27%	10.77%	11.10%	12.01%	15.83%	11.37%	13.96%
Return on Equity Simple (ROE_SIMPLE)	11.17%	10.30%	11.23%	10.96%	10.22%	10.71%	11.36%	14.60%	10.74%	12.88%
Net Operating Profit after Tax (NOPAT)	141	126	114	98	88	85	85	99	61	64
NOPAT Margin	14.80%	13.65%	12.14%	12.25%	12.56%	13.16%	13.20%	16.58%	11.08%	11.67%
Net Nonoperating Expense Percent (NNEP)	5.30%	4.85%	3.96%	2.50%	2.36%	3.02%	3.97%	3.73%	2.18%	1.80%
Return On Investment Capital (ROIC_SIMPLE)	10.37%	9.11%	8.12%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	64.75%	67.25%	70.24%	69.57%	68.18%	67.16%	68.27%	68.22%	67.31%	69.57%
SG&A Expenses to Revenue	14.31%	13.86%	13.06%	12.78%	14.56%	15.14%	13.29%	13.92%	14.95%	12.34%
R&D to Revenue	1.76%	1.63%	1.29%	1.69%	1.47%	1.77%	1.80%	1.56%	1.32%	1.08%
Operating Expenses to Revenue	16.07%	15.49%	14.35%	14.48%	16.02%	16.90%	15.09%	15.49%	16.27%	13.42%
Earnings before Interest and Taxes (EBIT)	183	160	144	128	111	102	107	96	90	94
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	231	215	196	177	162	148	151	140	136	134
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.61	4.53	4.14	6.16	4.43	4.31	3.56	4.05	4.92	3.97
Price to Tangible Book Value (P/TBV)	25.87	56.89	0.00	20.89	20.73	42.30	18.35	52.68	0.00	0.00
Price to Revenue (P/Rev)	5.56	5.17	4.12	6.76	5.22	4.98	3.83	4.20	4.64	3.33
Price to Earnings (P/E)	41.24	43.95	36.85	56.17	43.39	40.21	31.35	27.75	45.84	30.79
Dividend Yield	0.53%	0.53%	0.59%	0.38%	0.51%	0.52%	0.62%	0.54%	0.47%	0.58%
Earnings Yield	2.42%	2.28%	2.71%	1.78%	2.30%	2.49%	3.19%	3.60%	2.18%	3.25%
Enterprise Value to Invested Capital (EV/IC)	4.07	3.75	3.14	5.97	4.01	3.57	3.15	3.29	3.60	2.97
Enterprise Value to Revenue (EV/Rev)	5.73	5.46	4.55	6.77	5.35	5.27	4.00	4.51	5.09	3.72
Enterprise Value to EBITDA (EV/EBITDA)	23.64	23.44	21.88	30.62	23.21	22.89	17.00	19.12	20.64	15.39
Enterprise Value to EBIT (EV/EBIT)	29.84	31.49	29.76	42.34	33.95	33.14	24.12	27.95	31.21	21.96
Enterprise Value to NOPAT (EV/NOPAT)	38.68	39.99	37.47	55.25	42.58	40.08	30.27	27.21	45.91	31.91
Enterprise Value to Operating Cash Flow (EV/OCF)	30.00	27.40	30.94	33.68	25.01	27.27	21.67	24.26	26.16	19.81
Enterprise Value to Free Cash Flow (EV/FCFF)	37.78	34.25	0.00	41.12	37.46	0.00	30.70	40.82	0.00	33.45
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.18	0.31	0.50	0.13	0.21	0.34	0.24	0.36	0.55	0.65
Long-Term Debt to Equity	0.18	0.31	0.50	0.13	0.21	0.34	0.24	0.31	0.48	0.58
Financial Leverage	0.22	0.36	0.25	0.08	0.20	0.23	0.25	0.40	0.50	0.61
Leverage Ratio	1.44	1.62	1.56	1.39	1.48	1.49	1.49	1.68	1.86	2.04
Compound Leverage Factor	1.31	1.39	1.44	1.36	1.42	1.40	1.38	1.55	1.71	1.89
Debt to Total Capital	15.51%	23.74%	33.35%	11.22%	17.57%	25.64%	19.11%	26.71%	35.55%	39.49%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.16%	4.33%	4.57%
Long-Term Debt to Total Capital	15.51%	23.74%	33.35%	11.22%	17.57%	25.64%	19.11%	22.55%	31.22%	34.92%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	84.49%	76.26%	66.65%	88.78%	82.43%	74.36%	80.89%	73.29%	64.45%	60.51%
Debt to EBITDA	0.91	1.53	2.40	0.63	1.09	1.73	1.08	1.60	2.11	2.27
Net Debt to EBITDA	0.70	1.23	2.06	0.04	0.57	1.29	0.72	1.31	1.82	1.63
Long-Term Debt to EBITDA	0.91	1.53	2.40	0.63	1.09	1.73	1.08	1.35	1.85	2.00
Debt to NOPAT	1.50	2.61	4.11	1.13	2.00	3.03	1.92	2.28	4.69	4.70
Net Debt to NOPAT	1.14	2.09	3.52	0.08	1.04	2.25	1.28	1.87	4.06	3.38
Long-Term Debt to NOPAT	1.50	2.61	4.11	1.13	2.00	3.03	1.92	1.92	4.12	4.15
Altman Z-Score	9.47	7.09	5.11	12.10	8.41	6.40	7.05	6.06	5.18	4.34
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.99	2.12	2.40	2.24	2.83	2.76	2.76	1.84	1.87	2.44
Quick Ratio	1.07	1.28	1.41	1.53	1.94	1.72	1.87	1.21	1.21	1.79
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	145	147	-345	131	100	-51	84	66	-28	61
Operating Cash Flow to CapEx	515.55%	510.29%	278.53%	433.29%	446.03%	736.89%	632.81%	393.73%	467.27%	251.60%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	53.53	22.63	-8.49	11.01	8.73	-3.90	9.32
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	65.36	33.90	20.89	15.60	14.69	14.83	15.75
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	50.27	26.30	18.05	13.13	10.96	11.66	9.49
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.60	0.57	0.67	0.68	0.61	0.60	0.66	0.62	0.61	0.63
Accounts Receivable Turnover	7.79	7.18	7.57	7.41	7.34	6.67	6.75	6.82	7.70	8.34
Inventory Turnover	5.14	5.41	6.28	6.88	6.21	5.72	6.87	6.88	7.21	8.03
Fixed Asset Turnover	3.42	3.37	3.70	3.43	3.16	3.16	3.38	3.35	3.41	3.81
Accounts Payable Turnover	11.20	11.00	11.66	13.90	15.73	12.25	14.22	13.31	15.77	19.68
Days Sales Outstanding (DSO)	46.87	50.82	48.22	49.25	49.71	54.72	54.09	53.54	47.42	43.76
Days Inventory Outstanding (DIO)	71.03	67.42	58.10	53.08	58.78	63.77	53.11	53.04	50.65	45.44
Days Payable Outstanding (DPO)	32.58	33.19	31.31	26.26	23.21	29.81	25.66	27.42	23.15	18.54
Cash Conversion Cycle (CCC)	85.32	85.05	75.01	76.07	85.28	88.68	81.54	79.16	74.92	70.65
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,340	1,343	1,364	906	939	951	816	815	782	692
Invested Capital Turnover	0.71	0.68	0.83	0.87	0.74	0.73	0.79	0.75	0.75	0.80
Increase / (Decrease) in Invested Capital	-3.35	-21	459	-34	-12	135	1.18	33	90	2.97
Enterprise Value (EV)	5,460	5,035	4,286	5,406	3,763	3,394	2,572	2,684	2,815	2,057
Market Capitalization	5,299	4,771	3,883	5,399	3,671	3,204	2,463	2,499	2,566	1,839
Book Value per Share	$35.37	$32.69	$29.20	$27.08	$25.60	$23.12	$21.45	$19.28	$16.43	$14.71
Tangible Book Value per Share	$6.30	$2.60	($1.39)	$7.98	$5.47	$2.35	$4.16	$1.48	($2.09)	($1.75)
Total Capital	1,361	1,382	1,408	988	1,005	1,000	855	842	808	766
Total Debt	211	328	470	111	177	256	163	225	287	303
Total Long-Term Debt	211	328	470	111	177	256	163	190	252	268
Net Debt	162	264	403	7.63	92	191	109	184	249	218
Capital Expenditures (CapEx)	35	36	50	37	34	17	19	28	23	41
Debt-free, Cash-free Net Working Capital (DFCFNWC)	107	101	129	75	88	97	90	86	84	67
Debt-free Net Working Capital (DFNWC)	156	166	196	178	172	163	144	126	122	152
Net Working Capital (NWC)	156	166	196	178	172	163	144	91	87	117
Net Nonoperating Expense (NNE)	13	17	9.01	1.74	3.76	5.02	6.40	8.57	5.33	4.73
Net Nonoperating Obligations (NNO)	190	289	426	29	111	208	124	198	261	229
Total Depreciation and Amortization (D&A)	48	55	52	49	51	46	45	44	46	40
Debt-free, Cash-free Net Working Capital to Revenue	11.17%	10.98%	13.71%	9.41%	12.49%	15.07%	13.98%	14.38%	15.15%	12.20%
Debt-free Net Working Capital to Revenue	16.37%	17.97%	20.77%	22.33%	24.51%	25.27%	22.41%	21.17%	22.13%	27.54%
Net Working Capital to Revenue	16.37%	17.97%	20.77%	22.33%	24.51%	25.27%	22.41%	15.29%	15.81%	21.21%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.97	$3.38	$3.29	$2.98	$2.63	$2.48	$2.45	$2.83	$1.78	$1.92
Adjusted Weighted Average Basic Shares Outstanding	32.53M	32.27M	32.17M	32.19M	32.39M	32.25M	32.27M	32.04M	31.77M	31.54M
Adjusted Diluted Earnings per Share	$3.93	$3.35	$3.25	$2.94	$2.60	$2.45	$2.42	$2.79	$1.75	$1.89
Adjusted Weighted Average Diluted Shares Outstanding	32.53M	32.27M	32.17M	32.19M	32.39M	32.25M	32.27M	32.04M	31.77M	31.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.53M	32.27M	32.17M	32.19M	32.39M	32.25M	32.27M	32.04M	31.77M	31.54M
Normalized Net Operating Profit after Tax (NOPAT)	141	126	114	98	88	85	85	68	61	64
Normalized NOPAT Margin	14.80%	13.65%	12.14%	12.25%	12.56%	13.16%	13.20%	11.40%	11.08%	11.67%
Pre Tax Income Margin	17.45%	14.88%	14.19%	15.67%	15.12%	14.99%	15.39%	14.88%	14.99%	15.76%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	51.99	24.97	17.19	14.01	12.75	12.43	14.20
NOPAT to Interest Expense	0.00	0.00	0.00	39.84	19.91	14.21	11.16	13.10	8.45	9.78
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	36.91	17.37	14.36	11.55	9.02	9.26	7.94
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	24.76	12.31	11.38	8.70	9.37	5.28	3.52
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	19.91%	21.07%	19.66%	19.48%	19.74%	19.00%	17.09%	13.40%	19.15%	15.49%
Augmented Payout Ratio	24.33%	25.19%	53.28%	56.15%	35.65%	45.76%	18.87%	15.51%	21.99%	17.51%

This table displays calculated financial ratios and metrics derived from Balchem's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.53%	4.94%	4.35%	1.22%	3.06%	-1.65%	-5.86%	-2.30%	1.60%	9.10%	23.45%
EBITDA Growth	10.66%	10.61%	3.51%	1.72%	15.70%	11.48%	16.49%	9.28%	-3.85%	2.66%	8.98%
EBIT Growth	20.39%	22.68%	11.37%	4.37%	21.81%	15.77%	24.02%	8.32%	-9.53%	-1.21%	6.39%
NOPAT Growth	20.28%	16.64%	6.42%	6.06%	22.16%	11.02%	27.29%	10.91%	-8.95%	8.65%	7.75%
Net Income Growth	27.83%	26.02%	16.38%	6.51%	27.64%	24.49%	15.15%	1.10%	-21.50%	-14.20%	0.94%
EPS Growth	26.97%	25.61%	14.44%	5.38%	27.14%	24.24%	15.38%	1.09%	-21.35%	-12.00%	1.30%
Operating Cash Flow Growth	9.19%	-22.39%	10.27%	28.58%	-4.16%	61.82%	11.79%	-27.46%	396.20%	-6.37%	5.01%
Free Cash Flow Firm Growth	-88.74%	-24.40%	340.29%	221.14%	117.72%	112.01%	102.03%	83.35%	-18,473.56%	-829.90%	-872.12%
Invested Capital Growth	2.36%	-0.25%	0.29%	-2.12%	-2.70%	-1.55%	2.07%	6.80%	44.20%	50.68%	43.18%
Revenue Q/Q Growth	4.38%	0.03%	2.50%	-2.33%	4.79%	-0.54%	-0.56%	-0.55%	0.00%	-4.80%	3.20%
EBITDA Q/Q Growth	6.32%	-1.13%	1.54%	3.68%	6.27%	-7.49%	-0.21%	17.92%	2.40%	-3.34%	-6.38%
EBIT Q/Q Growth	7.53%	-1.38%	5.49%	7.62%	9.57%	-10.47%	-1.13%	25.60%	4.14%	-4.09%	-13.65%
NOPAT Q/Q Growth	10.08%	-3.19%	3.85%	8.67%	6.76%	-11.67%	3.51%	25.17%	-2.98%	1.27%	-9.81%
Net Income Q/Q Growth	10.33%	-0.75%	5.51%	10.64%	8.77%	-8.35%	-3.44%	32.58%	6.09%	-15.22%	-15.22%
EPS Q/Q Growth	9.71%	0.00%	5.10%	10.11%	8.54%	-8.89%	-3.23%	32.86%	6.06%	-15.38%	-15.22%
Operating Cash Flow Q/Q Growth	-30.32%	1.98%	14.02%	34.76%	-50.47%	44.88%	32.97%	0.44%	-16.37%	0.08%	-13.72%
Free Cash Flow Firm Q/Q Growth	-79.88%	18.32%	-48.70%	-7.81%	35.08%	589.14%	114.12%	86.51%	8.41%	-16.39%	-15.83%
Invested Capital Q/Q Growth	2.28%	-0.76%	1.20%	-0.35%	-0.32%	-0.23%	-1.23%	-0.94%	0.86%	3.43%	3.35%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.19%	35.97%	35.58%	35.46%	34.01%	32.79%	33.29%	33.45%	31.47%	29.52%	28.01%
EBITDA Margin	24.70%	24.25%	24.53%	24.77%	23.33%	23.01%	24.73%	24.64%	20.78%	20.30%	19.99%
Operating Margin	20.36%	19.77%	20.00%	19.56%	17.39%	16.76%	18.97%	18.52%	14.80%	14.32%	13.77%
EBIT Margin	20.30%	19.71%	19.99%	19.42%	17.63%	16.86%	18.73%	18.84%	14.92%	14.32%	14.22%
Profit (Net Income) Margin	14.79%	13.99%	14.10%	13.70%	12.09%	11.65%	12.64%	13.02%	9.77%	9.21%	10.34%
Tax Burden Percent	77.29%	75.49%	77.09%	77.79%	78.66%	80.10%	79.71%	78.41%	77.99%	83.05%	81.23%
Interest Burden Percent	94.25%	94.04%	91.51%	90.67%	87.22%	86.28%	84.69%	88.15%	83.96%	77.39%	89.51%
Effective Tax Rate	22.71%	24.51%	22.91%	22.21%	21.34%	19.90%	20.29%	21.59%	22.01%	16.95%	18.77%
Return on Invested Capital (ROIC)	11.21%	10.61%	10.78%	10.52%	9.37%	9.15%	10.51%	10.35%	9.37%	9.88%	9.21%
ROIC Less NNEP Spread (ROIC-NNEP)	10.08%	9.68%	9.50%	9.29%	8.22%	8.01%	8.98%	9.40%	7.66%	7.13%	8.31%
Return on Net Nonoperating Assets (RNNOA)	1.86%	2.10%	2.13%	2.54%	2.66%	2.88%	3.48%	3.60%	2.01%	1.78%	2.12%
Return on Equity (ROE)	13.07%	12.71%	12.91%	13.06%	12.02%	12.03%	13.99%	13.95%	11.37%	11.66%	11.33%
Cash Return on Invested Capital (CROIC)	8.58%	10.77%	9.80%	12.07%	12.45%	10.86%	7.16%	2.16%	-26.60%	-30.36%	-25.47%
Operating Return on Assets (OROA)	12.22%	11.85%	11.77%	11.34%	10.19%	9.65%	10.72%	10.99%	9.99%	9.56%	9.33%
Return on Assets (ROA)	8.90%	8.41%	8.30%	8.00%	6.99%	6.67%	7.24%	7.59%	6.54%	6.14%	6.78%
Return on Common Equity (ROCE)	13.07%	12.71%	12.91%	13.06%	12.02%	12.03%	13.99%	13.95%	11.37%	11.66%	11.33%
Return on Equity Simple (ROE_SIMPLE)	11.30%	0.00%	10.32%	10.50%	10.64%	0.00%	10.08%	9.88%	10.19%	0.00%	12.16%
Net Operating Profit after Tax (NOPAT)	39	36	37	36	33	31	35	34	27	28	27
NOPAT Margin	15.74%	14.92%	15.42%	15.22%	13.68%	13.43%	15.12%	14.52%	11.54%	11.89%	11.18%
Net Nonoperating Expense Percent (NNEP)	1.13%	0.93%	1.28%	1.23%	1.15%	1.13%	1.53%	0.95%	1.71%	2.75%	0.91%
Return On Investment Capital (ROIC_SIMPLE)	2.78%	2.63%	-	-	-	2.22%	-	-	-	1.96%	-
Cost of Revenue to Revenue	64.81%	64.03%	64.42%	64.54%	65.99%	67.21%	66.71%	66.55%	68.53%	70.48%	71.99%
SG&A Expenses to Revenue	12.97%	14.33%	13.77%	14.24%	14.91%	14.31%	12.64%	13.28%	15.19%	13.89%	13.02%
R&D to Revenue	1.86%	1.88%	1.80%	1.65%	1.71%	1.72%	1.68%	1.64%	1.48%	1.31%	1.23%
Operating Expenses to Revenue	14.83%	16.21%	15.57%	15.89%	16.62%	16.03%	14.32%	14.92%	16.67%	15.20%	14.25%
Earnings before Interest and Taxes (EBIT)	51	47	48	45	42	39	43	44	35	33	35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	62	58	59	58	56	53	57	57	48	47	49
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.47	4.61	4.85	4.49	4.63	4.53	3.88	4.29	4.16	4.14	4.31
Price to Tangible Book Value (P/TBV)	21.63	25.87	26.12	30.03	39.90	56.89	59.76	144.01	0.00	0.00	0.00
Price to Revenue (P/Rev)	5.60	5.56	6.06	5.35	5.37	5.17	4.29	4.59	4.28	4.12	4.18
Price to Earnings (P/E)	39.55	41.24	46.98	42.74	43.51	43.95	38.50	43.44	40.82	36.85	35.46
Dividend Yield	0.52%	0.53%	0.45%	0.51%	0.51%	0.53%	0.58%	0.53%	0.56%	0.59%	0.53%
Earnings Yield	2.53%	2.42%	2.13%	2.34%	2.30%	2.28%	2.60%	2.30%	2.45%	2.71%	2.82%
Enterprise Value to Invested Capital (EV/IC)	4.06	4.07	4.36	3.91	3.93	3.75	3.19	3.43	3.23	3.14	3.25
Enterprise Value to Revenue (EV/Rev)	5.77	5.73	6.24	5.59	5.65	5.46	4.64	4.97	4.70	4.55	4.64
Enterprise Value to EBITDA (EV/EBITDA)	23.48	23.64	26.10	23.34	23.63	23.44	20.57	23.48	22.84	21.88	21.87
Enterprise Value to EBIT (EV/EBIT)	29.03	29.84	33.77	30.79	31.39	31.49	27.88	32.44	31.50	29.76	29.41
Enterprise Value to NOPAT (EV/NOPAT)	37.62	38.68	43.23	38.95	39.87	39.99	35.03	40.57	39.79	37.47	38.10
Enterprise Value to Operating Cash Flow (EV/OCF)	30.05	30.00	29.85	27.11	28.83	27.40	27.20	30.55	26.75	30.94	30.31
Enterprise Value to Free Cash Flow (EV/FCFF)	47.82	37.78	44.51	32.03	31.10	34.25	45.02	164.40	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.18	0.18	0.21	0.26	0.30	0.31	0.39	0.42	0.48	0.50	0.54
Long-Term Debt to Equity	0.18	0.18	0.21	0.26	0.30	0.31	0.39	0.42	0.48	0.50	0.54
Financial Leverage	0.18	0.22	0.22	0.27	0.32	0.36	0.39	0.38	0.26	0.25	0.26
Leverage Ratio	1.40	1.44	1.45	1.51	1.57	1.62	1.68	1.69	1.53	1.56	1.58
Compound Leverage Factor	1.32	1.35	1.33	1.37	1.37	1.40	1.43	1.49	1.28	1.20	1.41
Debt to Total Capital	14.90%	15.51%	17.33%	20.43%	22.90%	23.74%	27.96%	29.58%	32.22%	33.35%	34.87%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	14.90%	15.51%	17.33%	20.43%	22.90%	23.74%	27.96%	29.58%	32.22%	33.35%	34.87%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	85.10%	84.49%	82.67%	79.57%	77.10%	76.26%	72.04%	70.42%	67.78%	66.65%	65.13%
Debt to EBITDA	0.89	0.91	1.09	1.28	1.44	1.53	1.90	2.12	2.38	2.40	2.45
Net Debt to EBITDA	0.68	0.70	0.77	0.99	1.17	1.23	1.54	1.79	2.07	2.06	2.16
Long-Term Debt to EBITDA	0.89	0.91	1.09	1.28	1.44	1.53	1.90	2.12	2.38	2.40	2.45
Debt to NOPAT	1.43	1.50	1.81	2.13	2.43	2.61	3.24	3.67	4.14	4.11	4.27
Net Debt to NOPAT	1.09	1.14	1.27	1.66	1.97	2.09	2.62	3.09	3.60	3.52	3.76
Long-Term Debt to NOPAT	1.43	1.50	1.81	2.13	2.43	2.61	3.24	3.67	4.14	4.11	4.27
Altman Z-Score	9.67	9.18	9.88	8.17	7.52	6.84	5.75	5.82	5.24	4.89	4.64
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.44	1.99	2.98	2.83	2.61	2.12	3.16	2.94	2.88	2.40	2.59
Quick Ratio	1.29	1.07	1.77	1.65	1.61	1.28	1.91	1.68	1.64	1.41	1.39
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	7.88	39	33	65	70	52	7.52	-53	-395	-431	-371
Operating Cash Flow to CapEx	655.82%	411.14%	560.80%	654.14%	483.18%	575.38%	560.76%	425.89%	360.49%	294.34%	277.58%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	12.97	0.00	0.00	0.00	-70.98	0.00	-101.73
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	6.19	0.00	0.00	0.00	6.26	0.00	11.43
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	4.91	0.00	0.00	0.00	4.52	0.00	7.31
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.60	0.60	0.59	0.58	0.58	0.57	0.57	0.58	0.67	0.67	0.66
Accounts Receivable Turnover	7.14	7.79	7.55	7.50	6.85	7.18	6.87	7.13	7.05	7.57	7.34
Inventory Turnover	4.87	5.14	5.26	5.09	5.27	5.41	4.93	4.91	5.69	6.28	5.85
Fixed Asset Turnover	3.46	3.42	3.45	3.43	3.38	3.37	3.50	3.59	3.66	3.70	3.77
Accounts Payable Turnover	9.89	11.20	12.84	11.12	10.94	11.00	10.27	10.65	13.25	11.66	11.65
Days Sales Outstanding (DSO)	51.15	46.87	48.33	48.64	53.25	50.82	53.16	51.16	51.77	48.22	49.73
Days Inventory Outstanding (DIO)	74.95	71.03	69.41	71.67	69.31	67.42	74.04	74.28	64.10	58.10	62.44
Days Payable Outstanding (DPO)	36.92	32.58	28.42	32.82	33.37	33.19	35.55	34.29	27.55	31.31	31.32
Cash Conversion Cycle (CCC)	89.17	85.32	89.32	87.50	89.19	85.05	91.65	91.16	88.31	75.01	80.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,371	1,340	1,350	1,334	1,339	1,343	1,346	1,363	1,376	1,364	1,319
Invested Capital Turnover	0.71	0.71	0.70	0.69	0.68	0.68	0.70	0.71	0.81	0.83	0.82
Increase / (Decrease) in Invested Capital	32	-3.35	3.89	-29	-37	-21	27	87	422	459	398
Enterprise Value (EV)	5,562	5,460	5,883	5,214	5,256	5,035	4,298	4,677	4,450	4,286	4,285
Market Capitalization	5,400	5,299	5,710	4,992	4,996	4,771	3,977	4,321	4,047	3,883	3,862
Book Value per Share	$37.15	$35.37	$36.29	$34.31	$33.27	$32.69	$31.80	$31.24	$30.26	$29.20	$27.89
Tangible Book Value per Share	$7.67	$6.30	$6.74	$5.13	$3.86	$2.60	$2.06	$0.93	($0.32)	($1.39)	($2.50)
Total Capital	1,420	1,361	1,424	1,398	1,399	1,382	1,423	1,430	1,436	1,408	1,376
Total Debt	212	211	247	286	321	328	398	423	463	470	480
Total Long-Term Debt	212	211	247	286	321	328	398	423	463	470	480
Net Debt	162	162	173	222	260	264	321	356	403	403	423
Capital Expenditures (CapEx)	5.56	13	9.15	6.88	6.91	12	8.30	8.22	9.66	14	15
Debt-free, Cash-free Net Working Capital (DFCFNWC)	151	107	143	143	140	101	156	155	159	129	170
Debt-free Net Working Capital (DFNWC)	201	156	217	207	200	166	233	222	219	196	226
Net Working Capital (NWC)	201	156	217	207	200	166	233	222	219	196	226
Net Nonoperating Expense (NNE)	2.38	2.23	3.16	3.56	3.80	4.06	5.69	3.48	4.12	6.25	2.06
Net Nonoperating Obligations (NNO)	162	190	173	222	260	289	321	356	403	426	423
Total Depreciation and Amortization (D&A)	11	11	11	13	14	14	14	13	14	14	14
Debt-free, Cash-free Net Working Capital to Revenue	15.63%	11.17%	15.16%	15.35%	15.07%	10.98%	16.87%	16.51%	16.79%	13.71%	18.37%
Debt-free Net Working Capital to Revenue	20.81%	16.37%	22.98%	22.18%	21.56%	17.97%	25.17%	23.62%	23.16%	20.77%	24.49%
Net Working Capital to Revenue	20.81%	16.37%	22.98%	22.18%	21.56%	17.97%	25.17%	23.62%	23.16%	20.77%	24.49%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.14	$1.03	$1.05	$0.99	$0.90	$0.82	$0.91	$0.94	$0.71	$0.67	$0.79
Adjusted Weighted Average Basic Shares Outstanding	32.62M	32.53M	32.51M	32.44M	32.42M	32.27M	32.24M	32.24M	32.23M	32.17M	32.14M
Adjusted Diluted Earnings per Share	$1.13	$1.03	$1.03	$0.98	$0.89	$0.82	$0.90	$0.93	$0.70	$0.66	$0.78
Adjusted Weighted Average Diluted Shares Outstanding	32.62M	32.53M	32.51M	32.44M	32.42M	32.27M	32.24M	32.24M	32.23M	32.17M	32.14M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.62M	32.53M	32.51M	32.44M	32.42M	32.27M	32.24M	32.24M	32.23M	32.17M	32.14M
Normalized Net Operating Profit after Tax (NOPAT)	39	36	37	36	33	31	35	34	27	28	27
Normalized NOPAT Margin	15.74%	14.92%	15.42%	15.22%	13.68%	13.43%	15.12%	14.52%	11.54%	11.89%	11.18%
Pre Tax Income Margin	19.14%	18.53%	18.29%	17.61%	15.38%	14.55%	15.86%	16.61%	12.52%	11.09%	12.73%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	7.83	0.00	0.00	0.00	6.23	0.00	9.54
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	6.07	0.00	0.00	0.00	4.82	0.00	7.50
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	6.55	0.00	0.00	0.00	4.50	0.00	5.42
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	4.79	0.00	0.00	0.00	3.09	0.00	3.38
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	20.71%	19.91%	21.04%	21.90%	22.26%	21.07%	22.15%	23.00%	23.07%	19.66%	19.03%
Augmented Payout Ratio	24.97%	24.33%	25.83%	26.83%	27.33%	25.19%	26.21%	27.17%	27.79%	53.28%	66.52%

Frequently Asked Questions About Balchem's Financials

When does Balchem's fiscal year end?

According to the most recent income statement we have on file, Balchem's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Balchem's net income changed over the last 9 years?

Balchem's net income appears to be on an upward trend, with a most recent value of $128.48 million in 2024, rising from $59.72 million in 2015. The previous period was $108.54 million in 2023. Find out what analysts predict for Balchem in the coming months.

What is Balchem's operating income?

Balchem's total operating income in 2024 was $182.91 million, based on the following breakdown:

Total Gross Profit: $336.21 million
Total Operating Expenses: $153.30 million

How has Balchem revenue changed over the last 9 years?

Over the last 9 years, Balchem's total revenue changed from $552.49 million in 2015 to $953.68 million in 2024, a change of 72.6%.

How much debt does Balchem have?

Balchem's total liabilities were at $425.46 million at the end of 2024, a 21.7% decrease from 2023, and a 2.3% increase since 2015.

How much cash does Balchem have?

In the past 9 years, Balchem's cash and equivalents has ranged from $38.64 million in 2016 to $103.24 million in 2021, and is currently $49.52 million as of their latest financial filing in 2024.

How has Balchem's book value per share changed over the last 9 years?

Over the last 9 years, Balchem's book value per share changed from 14.71 in 2015 to 35.37 in 2024, a change of 140.5%.

Related Companies

This page (NASDAQ:BCPC) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Balchem (BCPC) Financials

Frequently Asked Questions About Balchem's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Balchem (BCPC) Financials

Annual Income Statements for Balchem

Quarterly Income Statements for Balchem

Annual Cash Flow Statements for Balchem

Quarterly Cash Flow Statements for Balchem

Annual Balance Sheets for Balchem

Quarterly Balance Sheets for Balchem

Annual Metrics And Ratios for Balchem

Quarterly Metrics And Ratios for Balchem

Frequently Asked Questions About Balchem's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools